Skip to Content

JanOne Inc JAN

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

JanOne Inc focuses on reducing opioid addiction by finding treatments for conditions accompanied by pain and bring to market drugs and therapies with nonaddictive pain-relieving properties. The company operates in three operating segments, namely Biotechnology, Recycling, and Technology. It derives its majority of revenue from the Recycling segment that is primarily engaged in the recycling of appliances throughout the United States and Canada.

Contact
325 East Warm Springs Road, Suite 102
Las Vegas, NV, 89119
T +1 702 997-5968
Sector Industrials
Industry Waste Management
Most Recent Earnings Sep 30, 2021
Fiscal Year End Jan 1, 2022
Stock Type Distressed
Employees 179